We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




PerkinElmer Completes Acquisition of Caliper Life Sciences

By LabMedica International staff writers
Posted on 08 Nov 2011
Print article
PerkinElmer, Inc. (Waltham, MA, USA) announced the completion of the acquisition of Caliper Life Sciences, Inc. (Hopkinton, MA, USA), a leader in imaging and detection solutions for life sciences research, diagnostics, and environmental markets. PerkinElmer had announced its intent to acquire Caliper for approximately USD 600 million in cash, in September 2011.

The combined technology platforms of the companies will expand PerkinElmer's portfolio of solutions and services to provide broader offerings for molecular, cellular, animal and tissue imaging to enable translational medicine research, as well as add a microfluidics platform for genomics and proteomics applications and high-value sample preparation technologies for key scientific workflow areas such as Next Generation DNA Sequencing, with comprehensive solutions and services for identification of therapeutic response, biotherapeutics development and biologics QA/QC.

Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, "The integration of Caliper into our organization will further strengthen PerkinElmer's position in personalized medicine. The acquisition will enhance our ability to provide customers with the complementary technologies, services and knowledge they need to drive innovation from in vivo to in vitro imaging, and provide expanded offerings across our biomedical, diagnostics, environmental and food safety end-markets."

Friel added, "I am also very pleased to welcome Kevin Hrusovsky, who was Caliper's CEO, to PerkinElmer. Kevin will lead a newly combined USD 500 million business, which integrates the former Caliper organization with PerkinElmer's existing research business."

PerkinElmer designs and manufactures technology solutions for health and environmental concerns. The company reported revenues of approximately USD 1.7 billion in 2010, and has about 7,000 employees serving customers in more than 150 countries.

Related Links:
PerkinElmer
Caliper Life Sciences


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.